Exicure (XCUR) Non Operating Income (2016 - 2026)
Exicure's (XCUR) quarterly Non Operating Income came in at -$188000.0 in Q1 2026, down 316.09% YoY from $87000.0 in Q1 2025, and up 85.27% on a QoQ basis from -$1.3 million in Q4 2025.
Exicure (XCUR) Non Operating Income (2016 - 2026) Analysis & Trends
Exicure (XCUR) has 11 years of Non Operating Income data on file, last reported at -$188000.0 in Q1 2026.
- Quarterly Non Operating Income fell 316.09% year-over-year to -$188000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 million (down 161.93% YoY) and the FY2025 annual result came in at -$1.3 million, down 153.05% from the prior year.
- Non Operating Income grew to -$188000.0 in Q1 2026, from -$1.3 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.5 million in Q3 2024 to a low of -$1.9 million in Q3 2023.
- A 5-year average of -$85647.1 and a median of $11000.0 in 2022 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2023 — Non Operating Income slumped 4408.89% — and 2024, when it jumped 3609.09%.
- Tracing XCUR's Non Operating Income over 5 years: stood at $11000.0 in 2022, then changed by 0.0% to $11000.0 in 2023, then jumped by 3609.09% to $408000.0 in 2024, then slumped by 412.75% to -$1.3 million in 2025, then soared by 85.27% to -$188000.0 in 2026.
- The last three Non Operating Income figures came in at -$188000.0 (Q1 2026), -$1.3 million (Q4 2025), and -$46000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - | -67,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -188,000.00 |
| Dec 31, 2025 | -1.28 Mn |
| Sep 30, 2025 | -46,000.00 |
| Jun 30, 2025 | -112,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Dec 31, 2024 | 408,000.00 |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 635,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | -1.94 Mn |
| Jun 30, 2023 | -122,000.00 |
| Mar 31, 2023 | 132,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | -611,000.00 |
| Dec 31, 2021 | -376,000.00 |
| Sep 30, 2021 | -450,000.00 |
| Jun 30, 2021 | -407,000.00 |